Minimally Invasive Circulatory Assist Devices

Product Summary

Second Heart is developing a minimally invasive circulatory support platform based on proprietary aortic stent pump technology. The platform will be deployed using low profile catheter-based techniques and will provide either temporary or chronic circulatory support, depending on the specific needs of the patient. Second Heart’s initial product will be a catheter-based temporary assist pump to treat patients with acute decompensated heart failure and to provide circulatory support to those undergoing high-risk percutaneous coronary intervention (PCI). The second application will be a wirelessly powered circulatory assist pump that will provide chronic circulatory support for heart failure patients.

Key features of Second Heart’s platform include:

  • A higher flow (with lower RPMs) rate than other systems at over 7 liters per minute.
  • Pump placement just above the renal arteries will provide additional benefit for heart failure patients with kidney dysfunction.
  • A choice of pulsatile or continuous flow to optimize hemodynamics and lessen the risk of thrombosis.
  • The only system to use the full inner diameter of the aorta to increase pump stability and reduce pump migration.
  • Lower risk of mechanical failure due to simple impeller deployment mechanism, improved bearings, and liquid cooled drive shaft.

Latest News

Second Heart Assist Announces Successful Completion of Long-Duration Pre-Clinical Studies

First Long-Duration Clinical Studies in Cardio-Renal Syndrome Patients Now Scheduled to Take Place July 2020 in Tbilisi, Georgia NEWS PROVIDED BY Second Heart Assist, Inc. June 22nd, 2020 7:00am ET  Salt Lake City, Utah, June 22nd, 2020 /PRDistribution/ --...

Second Heart Assist to Present Clinical Data at American Society for Artificial Internal Organs 66th Annual Conference

Salt Lake City, UT (April 30th, 2020) - Following blind peer review, Second Heart Assist's clinical data presentation has been selected for oral presentation at the American Society of Artificial Organs (ASAIO) 66th annual conference, scheduled to be held entirely...

Second Heart Assist to Unveil Updated Wireless Power Design at ASAIO Annual Meeting

Salt Lake City, Utah, May 7th, 2020 - Second Heart Assist, the innovative developers of the world's first percutaneous placed true aortic stent based circulatory assist pumps, are delighted to announce that they will provide a brief update on their breakthrough...

Second Heart Assist Flow Model Demo Pulsaltility

Only system known that has the delicate balance right of firmly fixating to the aortic wall to avoid migration and re-positioning risks and at the same time being sufficiently compliant not to interfere with aortic wall motion and not to damage the aortic wall. You...

Howard Leonhardt and Alex Richardson of Second Heart Assist discuss regenerating hearts and novel medical devices

During their recent visit to Victoria BC for lab testing services, Second Heart Assist Chairman and CEO, Howard Leonhardt (HL), and VP of Engineering & Product Development, Alex Richardson (AR), spoke with ViVitro Lab and Interim General Manager, Rob Fraser (RF),...

OUR TEAM

Alex Richardson
VP Engineering & Product Development

Asli Gozoren
Chief Advisor, Investor Relations

Brittany Brown
Board Director

Dinesh Patel
Board Director

Howard Leonhardt
Chairman, CEO

Jane Reedy
Chief Advisor Clinical Affairs

Jeff Donofrio
President

Ken Evans
VP Corporate Development, Board Director

Kurt Kruger
Chief Advisor Biomedical Engineering & Finance

Larry Stevens
Chief Advisor Regulatory Affairs

Leslie Miller
Chief Medical Officer

Mark Cunningham
Chief Advisor CardioThoracic Surgery

Nic Chronos
Chief Advisor Research

Todd Seiger
Chief Advisor Reimbursement

Tom Newman
Associate Director Physician Relations